Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Myelodysplastic Syndromes 4Sarcoma, Myeloid 2Recurrence 2Leukemia, Monocytic, Acute 2Leukemia, Biphenotypic, Acute 2Leukemia 2Thyroid Cancer, Papillary 1Prostatic Neoplasms 1Philadelphia Chromosome 1Myeloproliferative Disorders 1Leukemia, Promyelocytic, Acute 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid 1Down Syndrome 1Burkitt Lymphoma 1

Interventions

fludarabine 7Whole-Body Irradiation 6Cyclophosphamide 6venetoclax 5fludarabine phosphate 5Tacrolimus 4Peripheral Blood Stem Cell Transplantation 4Mycophenolic Acid 4Busulfan 4asciminib 3gilteritinib 2blinatumomab 2aldesleukin 2Patient Reported Outcome Measures 2Mesna 2Melphalan 2Interleukin-2 2Idarubicin 2Cytarabine 2Bone Marrow Transplantation 2Azacitidine 2ponatinib 1nilotinib 1nicotinamide-beta-riboside 1methanesulfonic acid 1enasidenib 1Thiotepa 1Stem Cell Transplantation 1Social Determinants of Health 1Sirolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Myeloid × Mitoxantrone × 1 year × Clear all
NCT06429449 2026-01-15

Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia

University of Colorado, Denver

Phase 1 Recruiting
30 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Monocytic, Acute, Leukemia, Myeloid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡